Literature DB >> 14607900

Reprogramming of IL-10 activity and signaling by IFN-gamma.

Carmen Herrero1, Xiaoyu Hu, Wai Ping Li, Stuart Samuels, M Nusrat Sharif, Sergei Kotenko, Lionel B Ivashkiv.   

Abstract

One important mechanism of cross-regulation by opposing cytokines is inhibition of signal transduction, including inhibition of Janus kinase-STAT signaling by suppressors of cytokine signaling. We investigated whether IFN-gamma, a major activator of macrophages, inhibited the activity of IL-10, an important deactivator. Preactivation of macrophages with IFN-gamma inhibited two key anti-inflammatory functions of IL-10, the suppression of cytokine production and of MHC class II expression. Gene expression profiling showed that IFN-gamma broadly suppressed the ability of IL-10 to induce or repress gene expression. Although IFN-gamma induced expression of suppressor of cytokine signaling proteins, IL-10 signal transduction was not suppressed and IL-10 activation of Janus kinases and Stat3 was preserved. Instead, IFN-gamma switched the balance of IL-10 STAT activation from Stat3 to Stat1, with concomitant activation of inflammatory gene expression. IL-10 activation of Stat1 required the simultaneous presence of IFN-gamma. These results demonstrate that IFN-gamma operates a switch that rapidly regulates STAT activation by IL-10 and alters macrophage responses to IL-10. Dynamic regulation of the activation of different STATs by the same cytokine provides a mechanism by which cells can integrate and balance signals delivered by opposing cytokines, and extends our understanding of cross-regulation by opposing cytokines to include reprogramming of signaling and alteration of function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607900     DOI: 10.4049/jimmunol.171.10.5034

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  HIV-1 Infection Primes Macrophages Through STAT Signaling to Promote Enhanced Inflammation and Viral Replication.

Authors:  K Sofia Appelberg; Mark A Wallet; Jared P Taylor; Melanie N Cash; John W Sleasman; Maureen M Goodenow
Journal:  AIDS Res Hum Retroviruses       Date:  2017-04-12       Impact factor: 2.205

2.  IFNgamma primes macrophages for inflammatory activation by high molecular weight hyaluronan.

Authors:  Mark A Wallet; Shannon M Wallet; Giorgio Guiulfo; John W Sleasman; Maureen M Goodenow
Journal:  Cell Immunol       Date:  2010-02-24       Impact factor: 4.868

Review 3.  IL-10 production by CD4+ effector T cells: a mechanism for self-regulation.

Authors:  D Jankovic; D G Kugler; A Sher
Journal:  Mucosal Immunol       Date:  2010-03-03       Impact factor: 7.313

Review 4.  IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy.

Authors:  Lionel B Ivashkiv
Journal:  Nat Rev Immunol       Date:  2018-09       Impact factor: 53.106

5.  Kinetics of cytokine receptor trafficking determine signaling and functional selectivity.

Authors:  Jonathan Martinez-Fabregas; Stephan Wilmes; Luopin Wang; Majid Kazemian; Suman Mitra; Ignacio Moraga; Maximillian Hafer; Elizabeth Pohler; Juliane Lokau; Christoph Garbers; Adeline Cozzani; Paul K Fyfe; Jacob Piehler
Journal:  Elife       Date:  2019-11-27       Impact factor: 8.140

6.  Dietary n-3 polyunsaturated fatty acids suppress splenic CD4(+) T cell function in interleukin (IL)-10(-/-) mice.

Authors:  L H Ly; R Smith; R S Chapkin; D N McMurray
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

7.  Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses.

Authors:  Claire Gorby; Junel Sotolongo Bellón; Stephan Wilmes; Walid Warda; Elizabeth Pohler; Paul K Fyfe; Adeline Cozzani; Christophe Ferrand; Mark R Walter; Suman Mitra; Jacob Piehler; Ignacio Moraga
Journal:  Sci Signal       Date:  2020-09-15       Impact factor: 8.192

Review 8.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.

Authors:  Xiaoyu Hu; Lionel B Ivashkiv
Journal:  Immunity       Date:  2009-10-16       Impact factor: 31.745

9.  Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection.

Authors:  Seung-Hwan Lee; Kwang-Sin Kim; Nassima Fodil-Cornu; Silvia M Vidal; Christine A Biron
Journal:  J Exp Med       Date:  2009-08-31       Impact factor: 14.307

10.  IL-28 supplants requirement for T(reg) cells in protein sigma1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE).

Authors:  Agnieszka Rynda; Massimo Maddaloni; Javier Ochoa-Repáraz; Gayle Callis; David W Pascual
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.